NCT06624644
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06624644
Title A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Linnaeus Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Newport Beach RECRUITING Newport Beach California 92663 United States Details
UCSF RECRUITING San Francisco California 94143 United States Details
Stanford RECRUITING Stanford California 94305 United States Details
University of Colorado Anschutz RECRUITING Aurora Colorado 80045 United States Details
University of Colorado RECRUITING Denver Colorado 80204 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 87535 United States Details
Dana Farber RECRUITING Boston Massachusetts 02215 United States Details
University of New Mexico RECRUITING Albuquerque New Mexico 87106 United States Details
UPenn RECRUITING Philadelphia Pennsylvania 19107 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field